These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 28946393

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Cell Wall Associated Factors of Mycobacterium tuberculosis as Major Virulence Determinants: Current Perspectives in Drugs Discovery and Design.
    Singh G, Kumar A, Maan P, Kaur J.
    Curr Drug Targets; 2017 Nov 30; 18(16):1904-1918. PubMed ID: 28699515
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H, Namba K.
    Kekkaku; 2006 Dec 30; 81(12):753-74. PubMed ID: 17240921
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Drug targets exploited in Mycobacterium tuberculosis: Pitfalls and promises on the horizon.
    Bhat ZS, Rather MA, Maqbool M, Ahmad Z.
    Biomed Pharmacother; 2018 Jul 30; 103():1733-1747. PubMed ID: 29864964
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Emerging drugs and drug targets against tuberculosis.
    Lambert N, Abdalla AE, Duan X, Xie J.
    J Drug Target; 2017 Apr 30; 25(4):296-306. PubMed ID: 27822967
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Exploring Targets of Cell Wall Protein Synthesis and Overexpression Mediated Drug Resistance for the Discovery of Potential M. tb Inhibitors.
    Nandi S, Saxena AK.
    Curr Top Med Chem; 2021 Apr 30; 21(21):1922-1942. PubMed ID: 34315374
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New approaches to target the mycolic acid biosynthesis pathway for the development of tuberculosis therapeutics.
    North EJ, Jackson M, Lee RE.
    Curr Pharm Des; 2014 Apr 30; 20(27):4357-78. PubMed ID: 24245756
    [Abstract] [Full Text] [Related]

  • 16. DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization.
    Brecik M, Centárová I, Mukherjee R, Kolly GS, Huszár S, Bobovská A, Kilacsková E, Mokošová V, Svetlíková Z, Šarkan M, Neres J, Korduláková J, Cole ST, Mikušová K.
    ACS Chem Biol; 2015 Jul 17; 10(7):1631-6. PubMed ID: 25906160
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Potential Drug Targets in Mycobacterial Cell Wall: Non-Lipid Perspective.
    Das S, Hameed S, Fatima Z.
    Curr Drug Discov Technol; 2020 Jul 17; 17(2):147-153. PubMed ID: 29875004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.